ABCC8 and pulmonary arterial hypertension: All individuals within this cohort and the second cohort of 680 adult-onset PAH patients (NBR study) were screened for rare or novel variants in ABCC8. Eleven heterozygous predicted damaging ABCC8 variants were identified, seven of these were observed in the original cohort, including one familial case.